COVID-19 Vaccine Trials

Daewoong to conduct P1 trial of Covid-19 treatment in India

August 11, 2020August 11, 2020 THE COVID REMEDY trials

Daewoong Pharmaceutical said that the Indian health regulators have approved phase 1 clinical trial of its DWRX2003, a Covid-19 treatment.

Source: Daewoong to conduct P1 trial of Covid-19 treatment in India

← Phase-2 clinical trial of indigenously developed Covaxin for Covid-19 begins in Nagpur
COVID-19 survivor joins VCU Wright Center's clinical trial oversight committee →